REFERENCES
1. Yang JD, Roberts LR. Epidemiology and management of hepatocellular carcinoma. Infect Dis Clin North Am 2010;24:899-919, viii.
2. Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2021;7:6.
3. Cillo U, Vitale A, Polacco M, Fasolo E. Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit. Hepatology 2017;65:1741-8.
4. Khouzam S, Pagano D, Barbàra M, et al. Impact of Italian score for organ allocation system on deceased donor liver transplantation: a monocentric competing risk time-to-event analysis. Transplant Proc 2019;51:2860-4.
5. Shimamura T, Goto R, Watanabe M, Kawamura N, Takada Y. Liver transplantation for hepatocellular carcinoma: how should we improve the thresholds? Cancers (Basel) 2022;14:419.
6. Gruttadauria S, di Francesco F, Vizzini GB, et al. Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes. World J Gastroenterol 2009;15:4556-60.
7. Vogel A, Cervantes A, Chau I, et al. ESMO Guidelines Committee. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018;29:iv238-55.
8. Vogel A, Cervantes A, Chau I, et al. Correction to: “hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. Ann Oncol 2019;30:871-3.
9. Gruttadauria S, Pagano D, Corsini LR, et al. Impact of margin status on long-term results of liver resection for hepatocellular carcinoma: single-center time-to-recurrence analysis. Updates Surg 2020;72:109-17.
10. Kudo M, Han KH, Ye SL, et al. A changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-Pacific primary liver cancer expert consensus statements. Liver Cancer 2020;9:245-60.
11. Sato T, Kondo F, Ebara M, et al. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study. Hepatol Int 2015;9:330-6.
12. Coelho FF, Kruger JA, Fonseca GM, et al. Laparoscopic liver resection: experience based guidelines. World J Gastrointest Surg 2016;8:5-26.
13. Tranchart H, Di Giuro G, Lainas P, et al. Laparoscopic resection for hepatocellular carcinoma: a matched-pair comparative study. Surg Endosc 2010;24:1170-6.
14. Lee KF, Chong CN, Wong J, Cheung YS, Wong J, Lai P. Long-term results of laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma: a case-matched analysis. World J Surg 2011;35:2268-74.
15. van Dam RM, Wong-Lun-Hing EM, van Breukelen GJ, et al. ORANGE II Study Group. Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS® programme (ORANGE II-trial): study protocol for a randomised controlled trial. Trials 2012;13:54.
16. Le Roux F, Rebibo L, Cosse C, et al. Benefits of laparoscopic approach for resection of liver tumors in cirrhotic patients. J Laparoendosc Adv Surg Tech A 2018;28:553-61.
17. Allaire M, Goumard C, Lim C, Le Cleach A, Wagner M, Scatton O. New frontiers in liver resection for hepatocellular carcinoma. JHEP Rep 2020;2:100134.
18. Troisi RI, Berardi G, Morise Z, et al. Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study. Br J Surg 2021;108:196-204.
19. Krenzien F, Wabitsch S, Haber P, et al. Validity of the Iwate criteria for patients with hepatocellular carcinoma undergoing minimally invasive liver resection. J Hepatobiliary Pancreat Sci 2018;25:403-11.
20. Ortiz Galindo SA, Haber PK, Benzing C, et al. Safety of intermittent Pringle maneuver during minimally invasive liver resection in patients with hepatocellular carcinoma with and without cirrhosis. Langenbecks Arch Surg 2022;407:235-44.
21. Vega EA, Kutlu OC, Joechle K, De La Cruz N, Ko D, Conrad C. Preoperative prognosticators of safe laparoscopic hepatocellular carcinoma resection in advanced cirrhosis: a propensity score matching population-based analysis of 1799 western patients. J Gastrointest Surg 2019;23:1157-65.
22. Yu W, Rong W, Wang L, Wu F, Xu Q, Wu J. R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma. World J Surg 2014;38:1777-85.
23. Gruttadauria S, Pagano D, Liotta R, et al. Liver volume restoration and hepatic microarchitecture in small-for-size syndrome. Ann Transplant 2015;20:381-9.
24. Scilletta R, Pagano D, Spada M, et al. Comparative analysis of the incidence of surgical site infections in patients with liver resection for colorectal hepatic metastases after neoadjuvant chemotherapy. J Surg Res 2014;188:183-9.
25. Gruttadauria S, Saint Georges Chaumet M, Pagano D, et al. Impact of blood transfusion on early outcome of liver resection for colorectal hepatic metastases. J Surg Oncol 2011;103:140-7.
26. Gruttadauria S, Pagano D, Luca A, Gridelli B. Small-for-size syndrome in adult-to-adult living-related liver transplantation. World J Gastroenterol 2010;16:5011-5.
27. Gruttadauria S, Parikh V, Pagano D, et al. Early regeneration of the remnant liver volume after right hepatectomy for living donation: a multiple regression analysis. Liver Transpl 2012;18:907-13.
28. Enomoto S, Tamai H, Shingaki N, et al. Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis. Hepatol Int 2011;5:730-7.
29. Kim SS, Lee S, Kim MJ. Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma. Eur Radiol 2021;31:3405-16.
30. Gruttadauria S, Barbera F, Conaldi PG, et al. Clinical and molecular-based approach in the evaluation of hepatocellular carcinoma recurrence after radical liver resection. Cancers (Basel) 2021;13:518.
31. Bae JJ, Rho JW, Lee TJ, et al. Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients. Oncol Rep 2007;18:1007-13.
32. Fujiwara Y, Hoon DS, Yamada T, et al. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas. Jpn J Cancer Res 2000;91:287-92.
33. Levi Sandri GB, Lai Q, Ravaioli M, et al. The role of salvage transplantation in patients initially treated with open versus minimally invasive liver surgery: an intention-to-treat analysis. Liver Transpl 2020;26:878-87.
34. Aldrighetti L, Ratti F, Cillo U, et al. Italian Group of Minimally Invasive Liver Surgery (I GO MILS). Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry. Updates Surg 2017;69:271-83.
35. Gruttadauria S, Tropea A, Pagano D, et al. Mini-invasive approach contributes to expand the indication for liver resection for hepatocellular carcinoma without increasing the incidence of posthepatectomy liver failure and other perioperative complications: a single-center analysis. J Laparoendosc Adv Surg Tech A 2016;26:439-46.
